S-1 - Telomir Pharmaceuticals, Inc. (0001971532) (Filer)

1 min to read

S-1 – Telomir Pharmaceuticals, Inc. (0001971532) (Filer)

Filed: 2023-11-14 AccNo: 0001493152-23-040696 Size: 5 MB
Source: S-1 – Telomir Pharmaceuticals, Inc. (0001971532) (Filer)

A New Generation of SPACs Leads the Way Into 2025

After a two-and-a-half-year lull in SPAC activity, the second half of 2024 brought glimmers of sunshine to the otherwise gloomy...
OLNS#13 – M&A in German Tech: A Playbook for Buyers and Sellers – English

About the Orrick Legal Ninja Series – OLNS In substantially all of the major world markets, we have dedicated technology...
Updating Form 10-K for Fiscal Year 2024 and Other Reporting Reminders

With calendar year 2024 completed, US public companies with a December 31 fiscal year-end will be working to prepare their...
Bondi Paid in Trump Media Shares for SPAC Merger Consulting, Pledges to Divest – Sludge

Bondi Paid in Trump Media Shares for SPAC Merger Consulting, Pledges to Divest Sludge Source: Bondi Paid in Trump Media Shares...
S-4/A – Allovir, Inc. (0001754068) (Filer)

Filed: 2025-01-17 AccNo: 0001193125-25-008421 Size: 23 MB Source: S-4/A - Allovir, Inc. (0001754068) (Filer)